Sanskriti Varma1, Clare J Lee2, Todd T Brown3, Nisa M Maruthur4,5,6, Michael Schweitzer7, Thomas Magnuson7, Ihab Kamel8, Jeanne M Clark4,5,6. 1. The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. clee158@jhmi.edu. 3. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 4. Division of General Internal Medicine, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. 5. Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins University, Baltimore, MD, USA. 6. Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. 7. Department of Surgery, The Johns Hopkins University, Baltimore, MD, USA. 8. Department of Radiology, The Johns Hopkins University, Baltimore, MD, USA.
Abstract
OBJECTIVE: Bariatric surgery leads to more rapid and greater weight loss (WL) compared to medical weight loss (MWL), but the differences in body composition (BC) changes for these modalities remain unclear. Due to the known health risks associated with central adiposity, we compared the changes in regional distribution of fat mass (FM) and lean mass (LM) after surgical versus MWL. METHODS: In this 1:1:1 randomized trial among 15 persons with type 2 diabetes and body mass index (BMI) 30-39.9 kg/m2, we compared changes in BC, by dual-energy X-ray absorptiometry and abdominal computerized tomography, at time of 10%WL or 9 months after intervention (whichever came first). Participants underwent MWL, adjustable gastric banding (AGB), or Roux-en-Y gastric bypass (RYGB). Non-parametric tests evaluated BC differences (FM, LM, and visceral adipose tissue [VAT]) within and across all three arms and between pair-wise comparisons. RESULTS:Twelve female participants (75% African American) completed the study. Patient age, BMI, and baseline anthropometric characteristics were similar across study arms. AGB lost more LM (MWL - 5.2%, AGB - 10.3%, p = 0.021) and VAT (MWL + 10.9%, AGB - 28.0%, p = 0.049) than MWL. RYGB tended to lose more VAT (MWL +10.9%, RYGB - 20.2%, p = 0.077) than MWL. AGB tended to lose more LM than RYGB (AGB - 12.38%, RYGB - 7.29%, p = 0.15). CONCLUSIONS: At similar WL, AGB lost more LM and VAT than MWL; RYGB similarly lost more VAT. Given the metabolic benefits of reducing VAT and retaining LM, larger studies should confirm the changes in BC after surgical versus medical WL. CLINICAL TRIAL REGISTRATION: NCTDK089557 - ClinicalTrials.gov.
RCT Entities:
OBJECTIVE: Bariatric surgery leads to more rapid and greater weight loss (WL) compared to medical weight loss (MWL), but the differences in body composition (BC) changes for these modalities remain unclear. Due to the known health risks associated with central adiposity, we compared the changes in regional distribution of fat mass (FM) and lean mass (LM) after surgical versus MWL. METHODS: In this 1:1:1 randomized trial among 15 persons with type 2 diabetes and body mass index (BMI) 30-39.9 kg/m2, we compared changes in BC, by dual-energy X-ray absorptiometry and abdominal computerized tomography, at time of 10%WL or 9 months after intervention (whichever came first). Participants underwent MWL, adjustable gastric banding (AGB), or Roux-en-Y gastric bypass (RYGB). Non-parametric tests evaluated BC differences (FM, LM, and visceral adipose tissue [VAT]) within and across all three arms and between pair-wise comparisons. RESULTS: Twelve female participants (75% African American) completed the study. Patient age, BMI, and baseline anthropometric characteristics were similar across study arms. AGB lost more LM (MWL - 5.2%, AGB - 10.3%, p = 0.021) and VAT (MWL + 10.9%, AGB - 28.0%, p = 0.049) than MWL. RYGB tended to lose more VAT (MWL +10.9%, RYGB - 20.2%, p = 0.077) than MWL. AGB tended to lose more LM than RYGB (AGB - 12.38%, RYGB - 7.29%, p = 0.15). CONCLUSIONS: At similar WL, AGB lost more LM and VAT than MWL; RYGB similarly lost more VAT. Given the metabolic benefits of reducing VAT and retaining LM, larger studies should confirm the changes in BC after surgical versus medical WL. CLINICAL TRIAL REGISTRATION: NCTDK089557 - ClinicalTrials.gov.
Entities:
Keywords:
Bariatric surgery; Body composition; Clinical trial; Weight loss
Authors: Madeleine L Phillips; Mark C Lewis; Veronica Chew; Lilian Kow; John P Slavotinek; Lynne Daniels; Robin Valentine; Jim Toouli; Campbell H Thompson Journal: Obes Surg Date: 2005 Nov-Dec Impact factor: 4.129
Authors: Julia Schneider; Ralph Peterli; Markus Gass; Marc Slawik; Thomas Peters; Bettina K Wölnerhanssen Journal: Surg Obes Relat Dis Date: 2015-07-09 Impact factor: 4.734
Authors: Anita P Courcoulas; Nicholas J Christian; Steven H Belle; Paul D Berk; David R Flum; Luis Garcia; Mary Horlick; Melissa A Kalarchian; Wendy C King; James E Mitchell; Emma J Patterson; John R Pender; Alfons Pomp; Walter J Pories; Richard C Thirlby; Susan Z Yanovski; Bruce M Wolfe Journal: JAMA Date: 2013-12-11 Impact factor: 56.272
Authors: Lance E Davidson; Wen Yu; Bret H Goodpaster; James P DeLany; Elizabeth Widen; Thaisa Lemos; Gladys W Strain; Alfons Pomp; Anita P Courcoulas; Susan Lin; Isaiah Janumala; John C Thornton; Dympna Gallagher Journal: Obesity (Silver Spring) Date: 2018-05-30 Impact factor: 5.002